European Biotech Acquisition - Warrants (06/03/2026) Total Liabilities

As of the most recent data (December 2022), EBACW shows a total liabilities of $8.5M. That compares with $7.6M in the prior-year period — up 12.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBACW's total liabilities is now $8.5M (was $7.6M) — a 12.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.

Tracking EBACW's total liabilities over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $8.5M That compares with $7.6M in the prior-year period — up 12.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $8.5M) with ownership activity and broader fundamentals.